For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your settings we'll assume you’re happy.
If incorrect, please enter your country into the box below, to view site information related to your location.
Don't have an account?
We offer world-leading antibody development platforms based on a proprietary RabMAb® rabbit monoclonal platform, a phage display platform (AxioMx), and a next-generation sequencing platform (NGS-RabMAb®)
Custom product and licensing overview
We can help with downstream assay development for single-wash ELISA assays (SimpleStep ELISA®) and multiplex assays (FirePlex®)
AxioMx phage display technology
Visit protocols and troubleshooting or check them out using the Abcam app for iPhone
Protocols and troubleshooting
Full event breakdown with abstracts, speakers, registration and more
View global event calendar
View all pathways
View all interactive pathways
Abcam's RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies.
Learn how scientists combined the benefits of rabbit antibodies with those of a monoclonal and how this led to the breakthrough of our RabMAb technology; offering a consistent level of high quality antibodies.
In this webinar, learn more about RabMAb® technology and its unique advantages such as higher affinity and specificity compared to traditional antibodies, low background signal, diverse epitope recognition and more, and see what these can mean for your experiment.
Nature does an Inside View profile feature with Dr. Weimin Zhu, founder of the RabMAb® antibody platform and Senior Vice President of Antibody Technology
Mouse SimpleStep ELISA provide monoclonal specificity using RabMAb technology.
Advantages of high quality rabbit monoclonal products for Polyethylene Glycol (PEG) detection. Developed using RabMAb technology
Learn about next generation multiplex technology combining mass spectrometry with immunohistochemistry (IHC)for highly quantitative imaging of samples.
Nature's insideView interviews Michael Weiner, Vice President of Molecular Sciences, on how our technology portfolio can raise reproducibility standards.
Do you struggle using mouse monoclonals in mouse or rat? Do you experience cross-reactivity and high background from the anti-mouse secondary? Our RabMAb primary antibodies offer the perfect solution. Find out why.